We’re thrilled to share that the WOMAN-2 Trial has completed recruitment, with 15,000 women randomised across sites in Nigeria, Pakistan, Tanzania, and Zambia. With the unwavering commitment of these dedicated teams, we were able to complete recruitment in September 2023, bringing us a step closer to creating meaningful change for women worldwide.
Professor Rizwana Chaudhri and Professor Ian Roberts speak with The Lancet Global Health about research carried out by the WOMAN Trials collaborators investigating the link between maternal anaemia and postpartum haemorrhage.
Evidence from the WOMAN-2 Trial shows that pregnant women with anaemia are substantially more likely to suffer life-threatening bleeding after childbirth. This video shows how anaemia can increase risk of …
Professor Ian Roberts and Professor Camara Phyllis Jones comment in The Lancet on the link between postpartum haemorrhage, iron deficiency anaemia and structural racism.
The WOMAN-2 Trial found that a reduction in haemoglobin of 10 grams per litre of blood just before birth increased the risk of life threatening bleeding after childbirth by 23%.
Haleema Shakur-Still is Emeritus Professor of Global Health Clinical Trials at the London School of Hygiene & Tropical Medicine and Co-Principal Investigator of the WOMAN-2 Trial.
Ian Roberts, Professor of Epidemiology and Co-Director of the Clinical Trials Unit at the London School of Hygiene & Tropical Medicine, highlights the need to treat heavy menstrual bleeding as a …
December 19 2009 was one of the best days of my life and also one of the worst. It was nearly the last day of my life. Early that morning …
Dying in childbirth? It’s something I thought didn’t happen in the UK, that was, until it nearly happened to me. I gave birth to my fraternal twins and experienced a …
Visit FaceBook